Antibe Therapeutics Inc. (ATBPF)
USD 0.22
(0.0%)
USD 0.22
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 9.71 Million | 9.98 Million | 9.53 Million | 8.51 Million |
| Cost of Revenue | - | 99 Thousand | 6.16 Million | 6.09 Million | 5.98 Million | 5.13 Million |
| Gross Profit | - | -99 Thousand | 3.55 Million | 3.88 Million | 3.54 Million | 3.37 Million |
| Operating Expenses | 20.54 Million | 25.52 Million | 27.81 Million | 21.2 Million | 15.73 Million | 10.03 Million |
| Selling, General and Administrative Expenses | 9.23 Million | 11.17 Million | 13.9 Million | 12.55 Million | 11.37 Million | 6.91 Million |
| Research and Development Expenses | 11.3 Million | 14.35 Million | 13.42 Million | 8.07 Million | 3.94 Million | 2.74 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 20.54 Million | 25.52 Million | 33.97 Million | 27.3 Million | 21.72 Million | 15.17 Million |
| Operating Income | -20.54 Million | -25.52 Million | -24.71 Million | -18.91 Million | -12.18 Million | -6.66 Million |
| Interest Expense | 8000.00 | 8000.00 | 236 Thousand | 500 Thousand | 430.28 Thousand | 1.17 Million |
| Income Tax Expense | 184 Thousand | -182 Thousand | 1.8 Million | -7000.00 | 134.12 Thousand | -274.76 Thousand |
| Earnings before Tax | -19.29 Million | -25.25 Million | -24.73 Million | -19.34 Million | -12.68 Million | -7.7 Million |
| Net Income | -19.47 Million | -25.06 Million | -26.3 Million | -19.34 Million | -12.81 Million | -7.42 Million |
| Earnings Per Share Basic | -0.37 | -0.49 | -0.71 | -0.71 | -0.60 | -0.49 |
| Earnings Per Share Diluted | -0.37 | -0.49 | -0.71 | -0.71 | -0.60 | -0.49 |
| Weighted Average Shares Outstanding | 52.28 Million | 50.77 Million | 37.25 Million | 27.26 Million | 21.48 Million | 15.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.28 Million | 50.77 Million | 37.25 Million | 27.26 Million | 21.48 Million | 15.16 Million |
| Gross Margin | - | - | 0.37 | 0.39 | 0.37 | 0.40 |
| EBIT Margin | - | - | -2.44 | -1.67 | -1.23 | -0.74 |
| Profit Margin | - | - | -2.71 | -1.94 | -1.34 | -0.87 |
| EBITDA | -20.44 Million | -25.14 Million | -23.73 Million | -17.97 Million | -11.83 Million | -6.14 Million |
| Earnings Before Tax Margin | - | - | -2.54 | -1.89 | -1.28 | -0.78 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 4.59 Million | 5.44 Million | 6.28 Million | 3.58 Million | 20.54 Million | 4.66 Million |
| Selling, General and Administrative Expenses | 2.29 Million | 1.95 Million | 2.71 Million | 2.19 Million | - | 2.43 Million |
| Research and Development Expenses | 2.3 Million | 3.49 Million | 3.56 Million | 1.39 Million | - | 2.23 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 4.59 Million | 5.44 Million | 6.28 Million | 3.58 Million | 20.54 Million | 4.66 Million |
| Operating Income | -4.59 Million | -5.44 Million | -6.28 Million | -3.58 Million | -20.54 Million | -4.66 Million |
| Interest Expense | 2000.00 | 2000.00 | 2000.00 | 2000.00 | 8000.00 | 2000.00 |
| Income Tax Expense | -442.00 | -462 Thousand | -482 Thousand | -41 Thousand | -1.16 Million | 111 Thousand |
| Earnings before Tax | -4.21 Million | -5 Million | -5.78 Million | -3.23 Million | -19.29 Million | -4.2 Million |
| Net Income | -4.21 Million | -5 Million | -5.78 Million | -3.54 Million | -19.47 Million | -4.31 Million |
| Earnings Per Share Basic | -0.08 | -0.10 | -0.11 | -0.07 | - | -0.08 |
| Earnings Per Share Diluted | -0.08 | -0.10 | -0.11 | -0.07 | - | -0.08 |
| Weighted Average Shares Outstanding | 52.65 Million | 52.63 Million | 52.63 Million | 52.61 Million | 52.28 Million | 52.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 52.65 Million | 52.63 Million | 52.63 Million | 52.61 Million | 52.28 Million | 52.32 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -4.59 Million | -4.98 Million | -5.79 Million | -3.22 Million | - | -4.2 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NXGPF
BORT
ELGIEQUIP
CDSL
LEENEE
ONVC